Overview
An anionic surface-active agent used for its wetting properties in industry and used in medicine as an irritant and sclerosing agent for hemorrhoids and varicose veins.
Background
An anionic surface-active agent used for its wetting properties in industry and used in medicine as an irritant and sclerosing agent for hemorrhoids and varicose veins.
Indication
For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.
Associated Conditions
- Uncomplicated competent valves, simple dilation varicose veins of legs
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2023/10/30 | Phase 3 | Recruiting | |||
2022/10/28 | Phase 2 | Not yet recruiting | Goldman, Butterwick, Fitzpatrick and Groff | ||
2020/12/07 | Early Phase 1 | UNKNOWN | Combined Military Hospital, Pakistan | ||
2018/07/11 | Phase 2 | Recruiting | University Hospital, Limoges | ||
2017/12/06 | Not Applicable | Terminated | Ellen Dillavou | ||
2015/12/11 | Phase 4 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. (dba Leucadia Pharmaceuticals) | 24201-201 | INTRAVENOUS | 30 mg in 1 mL | 1/10/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| FIBRO-VEIN SOLUTION FOR INJECTION 0.5% W/V | N/A | N/A | N/A | 11/11/2013 | |
| FIBRO-VEIN SOLUTION FOR INJECTION 3% W/V | N/A | N/A | N/A | 11/11/2013 | |
| FIBRO-VEIN SOLUTION FOR INJECTION 1% W/V | N/A | N/A | N/A | 11/11/2013 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| FIBROVEIN 0.5% sodium tetradecyl sulfate 10mg/2mL injection ampoule | 73361 | Medicine | A | 9/4/2000 | |
| FIBROVEIN 3% sodium tetradecyl sulfate 30mg/1mL multidose injection vial | 29772 | Medicine | A | 10/25/1991 | |
| FIBROVEIN 1.0% sodium tetradecyl sulfate 20mg/2ml injection ampoule | 73362 | Medicine | A | 9/4/2000 | |
| FIBROVEIN 3% sodium tetradecyl sulfate 60mg/2mL injection ampoule | 29638 | Medicine | A | 10/25/1991 |